BRCA1 & BRCA2 MUTATION SCREEN
Understanding BRCA1 & BRCA2 Mutation Screening
Introduction to BRCA1 and BRCA2 Mutations
BRCA1 and BRCA2 are genes that produce proteins responsible for repairing damaged DNA. Mutations in these genes can impair their function, leading to an increased risk of developing certain types of cancer, most notably breast and ovarian cancers. Women with BRCA1 or BRCA2 mutations have a significantly higher risk of these cancers compared to the general population. Men with these mutations also face elevated risks, particularly for breast cancer and prostate cancer.
Symptoms and Causes of BRCA1 and BRCA2 Mutations
Symptoms:
- Family History of Cancer: A strong family history of breast, ovarian, prostate, or pancreatic cancer can indicate a potential BRCA mutation.
- Early Onset Cancer: Individuals diagnosed with breast or ovarian cancer at a younger age than typically expected may have a BRCA mutation.
- Multiple Cancer Diagnoses: People who have had more than one cancer diagnosis or multiple primary cancers might be carriers of these mutations.
Causes:
- Genetic Inheritance: BRCA1 and BRCA2 mutations are inherited in an autosomal dominant pattern. This means that having one copy of the mutated gene from either parent can significantly increase cancer risk.
- Genetic Mutations: The mutations can occur in the BRCA1 or BRCA2 genes, which are crucial for repairing DNA. When these genes are mutated, their ability to repair damaged DNA is compromised, leading to cancer development.
Tests to Diagnose BRCA1 and BRCA2 Mutations
- Genetic Testing: The primary test for diagnosing BRCA1 and BRCA2 mutations is a genetic test, which involves analysing a blood sample or, occasionally, other types of tissue samples to detect mutations in these genes.
- Family History Assessment: Healthcare providers often start by evaluating a patient's family history of cancer to determine the likelihood of a BRCA mutation before proceeding with genetic testing.
- Clinical Evaluation: Following genetic testing, a clinical evaluation may be conducted to assess the risk of cancer based on the presence of BRCA mutations and other personal health factors.
Introduction to BRCA1 & BRCA2 Mutation Screening
What is the BRCA1 & BRCA2 Mutation Screen?
The BRCA1 & BRCA2 Mutation Screen is a genetic test designed to identify mutations in the BRCA1 and BRCA2 genes. This test helps in determining an individual’s risk of developing breast, ovarian, and other cancers associated with these gene mutations. By identifying mutations, the test provides crucial information for risk assessment and decision-making regarding preventive measures and treatment options.
Who Should Get the BRCA1 & BRCA2 Mutation Screen Done?
- Individuals with a Family History of Cancer: Those with a family history of breast, ovarian, prostate, or pancreatic cancer should consider genetic testing, especially if multiple relatives have been affected or if cancers occurred at a young age.
- Cancer Survivors: People who have had breast or ovarian cancer, particularly if diagnosed at a young age or if they have had multiple cancer diagnoses, might benefit from this test.
- People with Known Family Mutations: If a close relative has tested positive for a BRCA1 or BRCA2 mutation, other family members may also choose to be tested to understand their own risk.
What Does the BRCA1 & BRCA2 Mutation Screen Measure?
- Gene Mutations: The test measures the presence of specific mutations in the BRCA1 and BRCA2 genes. Identifying these mutations helps in assessing the risk of developing related cancers.
- Risk Assessment: By detecting mutations, the test provides information on an individual's risk of developing breast, ovarian, and other cancers, enabling more informed decisions about monitoring and prevention.
How to Prepare for the BRCA1 & BRCA2 Mutation Screen?
1. Consult Your Healthcare Provider: Before undergoing the test, speak with a genetic counsellor or healthcare provider to discuss the potential implications and benefits of the test based on your family history and personal health.
2. No Special Preparation Required: Typically, there is no need for special preparation before the test. However, ensure that you follow any specific instructions provided by your healthcare provider.
3. Understanding the Results: Be prepared to discuss the results with a genetic counsellor or healthcare provider. They will help interpret the results and discuss potential next steps, including risk management strategies and preventive measures.
Conclusion
The BRCA1 & BRCA2 Mutation Screen is a vital tool in identifying genetic mutations that significantly increase the risk of breast, ovarian, and other cancers. Understanding these risks allows individuals and their healthcare providers to make informed decisions about prevention, surveillance, and treatment. With advances in genetic testing, those with a family history of related cancers or known gene mutations can gain valuable insights into their health and take proactive steps to manage their cancer risk effectively.
Medically reviewed by Apollo Diagnostics
Clinical information verified by our diagnostics team
Also known as
BRCA1 & BRCA2 MUTATION SCREEN
Sample type
Blood
Gender
Male & Female
Age group
All age groups
Fasting required
No special preparation is required for the test.
Report delivery
21 DAYS
Parameters
Test specific
Diagnostic Test prerequisites: No special preparation is required for the test.
APOLLO DIRECT PRICE
BRCA1 & BRCA2 MUTATION SCREEN
₹7500
₹10000
25% off
Sample Type :
Blood
Report Delivery :
21 DAYS
Pre-test Information :
No special preparation is required for the test.
Safe and hygienic sample collection
Experienced phlebotomists
Quality-assured diagnostic processing
Digital report access
Special Offers for You
Smart savings and convenient services with your booking.
Home sample collection
Convenient collection available in Hyderabad
Apollo quality assurance
Reliable processing at accredited diagnostic laboratories
Digital reports
Access your diagnostic reports online when ready
Trusted Diagnostics. Quality You Can Rely On.
Apollo standards across collection, processing and reporting
1500+
Diagnostic centres
10M+
Tests processed annually
NABL & CAP
Accredited laboratory
Home
Sample collection
Digital
Report access
Understanding BRCA1 & BRCA2 Mutation Screening
Introduction to BRCA1 and BRCA2 Mutations
BRCA1 and BRCA2 are genes that produce proteins responsible for repairing damaged DNA. Mutations in these genes can impair their function, leading to an increased risk of developing certain types of cancer, most notably breast and ovarian cancers. Women with BRCA1 or BRCA2 mutations have a significantly higher risk of these cancers compared to the general population. Men with these mutations also face elevated risks, particularly for breast cancer and prostate cancer.
Symptoms and Causes of BRCA1 and BRCA2 Mutations
Symptoms:
- Family History of Cancer: A strong family history of breast, ovarian, prostate, or pancreatic cancer can indicate a potential BRCA mutation.
- Early Onset Cancer: Individuals diagnosed with breast or ovarian cancer at a younger age than typically expected may have a BRCA mutation.
- Multiple Cancer Diagnoses: People who have had more than one cancer diagnosis or multiple primary cancers might be carriers of these mutations.
Causes:
- Genetic Inheritance: BRCA1 and BRCA2 mutations are inherited in an autosomal dominant pattern. This means that having one copy of the mutated gene from either parent can significantly increase cancer risk.
- Genetic Mutations: The mutations can occur in the BRCA1 or BRCA2 genes, which are crucial for repairing DNA. When these genes are mutated, their ability to repair damaged DNA is compromised, leading to cancer development.
Tests to Diagnose BRCA1 and BRCA2 Mutations
- Genetic Testing: The primary test for diagnosing BRCA1 and BRCA2 mutations is a genetic test, which involves analysing a blood sample or, occasionally, other types of tissue samples to detect mutations in these genes.
- Family History Assessment: Healthcare providers often start by evaluating a patient's family history of cancer to determine the likelihood of a BRCA mutation before proceeding with genetic testing.
- Clinical Evaluation: Following genetic testing, a clinical evaluation may be conducted to assess the risk of cancer based on the presence of BRCA mutations and other personal health factors.
Introduction to BRCA1 & BRCA2 Mutation Screening
What is the BRCA1 & BRCA2 Mutation Screen?
The BRCA1 & BRCA2 Mutation Screen is a genetic test designed to identify mutations in the BRCA1 and BRCA2 genes. This test helps in determining an individual’s risk of developing breast, ovarian, and other cancers associated with these gene mutations. By identifying mutations, the test provides crucial information for risk assessment and decision-making regarding preventive measures and treatment options.
Who Should Get the BRCA1 & BRCA2 Mutation Screen Done?
- Individuals with a Family History of Cancer: Those with a family history of breast, ovarian, prostate, or pancreatic cancer should consider genetic testing, especially if multiple relatives have been affected or if cancers occurred at a young age.
- Cancer Survivors: People who have had breast or ovarian cancer, particularly if diagnosed at a young age or if they have had multiple cancer diagnoses, might benefit from this test.
- People with Known Family Mutations: If a close relative has tested positive for a BRCA1 or BRCA2 mutation, other family members may also choose to be tested to understand their own risk.
What Does the BRCA1 & BRCA2 Mutation Screen Measure?
- Gene Mutations: The test measures the presence of specific mutations in the BRCA1 and BRCA2 genes. Identifying these mutations helps in assessing the risk of developing related cancers.
- Risk Assessment: By detecting mutations, the test provides information on an individual's risk of developing breast, ovarian, and other cancers, enabling more informed decisions about monitoring and prevention.
How to Prepare for the BRCA1 & BRCA2 Mutation Screen?
1. Consult Your Healthcare Provider: Before undergoing the test, speak with a genetic counsellor or healthcare provider to discuss the potential implications and benefits of the test based on your family history and personal health.
2. No Special Preparation Required: Typically, there is no need for special preparation before the test. However, ensure that you follow any specific instructions provided by your healthcare provider.
3. Understanding the Results: Be prepared to discuss the results with a genetic counsellor or healthcare provider. They will help interpret the results and discuss potential next steps, including risk management strategies and preventive measures.
Conclusion
The BRCA1 & BRCA2 Mutation Screen is a vital tool in identifying genetic mutations that significantly increase the risk of breast, ovarian, and other cancers. Understanding these risks allows individuals and their healthcare providers to make informed decisions about prevention, surveillance, and treatment. With advances in genetic testing, those with a family history of related cancers or known gene mutations can gain valuable insights into their health and take proactive steps to manage their cancer risk effectively.
BRCA1 & BRCA2 MUTATION SCREEN Price in Different Cities
Check Apollo Diagnostics pricing across major cities in India.
CITY
PRICE
VERIFIED CUSTOMER REVIEWS
What Our Patients Say
Families across India trust Apollo Diagnostics for convenient sample collection and reliable reports.
Mr. Shahul Hameed
Chennai • Verified Patient
Mr. Laxmi Kantham
Hyderabad • Verified Patient
Shivaraj Kadam
Pune • Verified Patient
Book Your BRCA1 & BRCA2 MUTATION SCREEN Today
NABL accredited testing, certified phlebotomists, and digital reports at ₹7500.
No Hidden Charges • Flexible Time Slots